Prosecution Insights
Prosecution Insights
8 pending office actions • 5 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 3 (38%) |
| Double-patenting + other | 2 (25%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KENYON, JOHN S | 1 | 80.2% | +17.5% |
| ARCORIA, PAUL JOSEPH | 1 | — | — |
| NOTTINGHAM, KYLE GREGORY | 1 | 59.3% | +34.9% |
| LEE, WILLIAM Y | 1 | 48.0% | +33.8% |
| MILLER, DALE R | 1 | 62.4% | +17.4% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| ROBINSON, MIKHAIL O'DONNEL | 1 | 58.9% | +41.5% |
| HUTTER, GILLIAN A | 1 | 54.2% | +46.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18013696 | OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | 3d overdue |
| 18841895 | ISOQUINOLINONE COMPOUND, AND PREPARATION METHOD AND USE THEREFOR | KENYON, JOHN S | — |
| 18560605 | HETEROCYCLIC COMPOUND FOR INHIBITING SHP2 ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | LEE, WILLIAM Y | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17765354 | DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF | HUTTER, GILLIAN A | 49d overdue |
| 18286416 | NUCLEOSIDE ANALOG AND USE THEREOF | MILLER, DALE R | 17d overdue |
| 18013696 | OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | 3d overdue |
| 18841895 | ISOQUINOLINONE COMPOUND, AND PREPARATION METHOD AND USE THEREFOR | KENYON, JOHN S | — |
| 18574511 | BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF | NOTTINGHAM, KYLE GREGORY | — |
| 18560605 | HETEROCYCLIC COMPOUND FOR INHIBITING SHP2 ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | LEE, WILLIAM Y | — |
| 18267298 | THYROID HORMONE RECEPTOR b SELECTIVE AGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | ROBINSON, MIKHAIL O'DONNEL | — |
| Art Unit | Apps |
|---|---|
| 1621 | 2 |
| 1623 | 1 |
| 1693 | 1 |
| 1627 | 1 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18841895 | ISOQUINOLINONE COMPOUND, AND PREPARATION METHOD AND USE THEREFOR | KENYON, JOHN S | — | §101§102§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18839865 | SALT OF SUBSTITUTED AMINO SIX-MEMBERED NITRIC HETEROCYCLIC COMPOUND, CRYSTAL FORM THEREOF, METHOD FOR PREPARING SAME, AND USE THEREOF | ARCORIA, PAUL JOSEPH | — | §103 | Non-Final OA | — | Pending | Aug 20, 2024 |
| 18574511 | BRUTON'S TYROSINE KINASE AND MUTANT DEGRADER, COMPOSITION AND APPLICATION THEREOF | NOTTINGHAM, KYLE GREGORY | 1621 | §102§103DPOther | Non-Final OA | — | Pending | Dec 27, 2023 |
| 18560605 | HETEROCYCLIC COMPOUND FOR INHIBITING SHP2 ACTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF | LEE, WILLIAM Y | 1623 | §103§112 | Non-Final OA | — | Pending | Nov 13, 2023 |
| 18286416 | NUCLEOSIDE ANALOG AND USE THEREOF | MILLER, DALE R | 1693 | §103§112DP | Final Rejection | 17d overdue | Pending | Oct 11, 2023 |
| 18013696 | OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF | O DELL, DAVID K | 1621 | §103§112 | Final Rejection | 3d overdue | Pending | Aug 10, 2023 |
| 18267298 | THYROID HORMONE RECEPTOR b SELECTIVE AGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF | ROBINSON, MIKHAIL O'DONNEL | 1627 | §103 | Non-Final OA | — | Pending | Jun 14, 2023 |
| 17765354 | DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF | HUTTER, GILLIAN A | 1625 | §103 | Final Rejection | 49d overdue | Pending | Mar 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial